文献速递细菌感染、耐药与抗菌药物医院感染防控

常规全基因组测序在多药耐药病原体医院感染控制中的临床实施

Clinical Implementation of Routine Whole-genome Sequencing for Hospital Infection Control of Multi-drug Resistant Pathogens.
PubMed 文献 · Clin Infect Dis · 2023-01-01

在澳大利亚布里斯班三家三级转诊医院(2家成人、1家儿童)前瞻性收集血液、无菌部位或筛查标本中的MRSA、VRE、CRAB、ESBL-E和CPE,4年内对2660株分离株进行WGS并生成379份临床报告;33%的分离株形成76个不同聚类,其中43个聚类局限于3家目标医院,提示临床环境内持续传播;结果表明临床实验室常规WGS用于MDR病原体是可行的,并能支持有针对性的感染预防与控制干预。

要点

  • 4年内对2660株多药耐药分离株进行WGS,共发布379份临床报告。
  • 33%的分离株形成76个不同聚类,其中43个聚类局限于3家目标医院。
  • 在1家医院,非多药耐药MRSA传播可忽略的证据促使感染控制政策变更。

核心结论

  • 在临床实验室对多药耐药病原体实施常规WGS是可行的,并能支持有针对性的感染预防与控制干预。

研究设计与样本

  • 前瞻性收集澳大利亚布里斯班三家三级转诊医院(2家成人、1家儿童)的MRSA、VRE、CRAB、ESBL-E和CPE分离株,来源包括血液培养、无菌部位或筛查标本。
  • 使用WGS通过定制基因组分析流程进行in silico多位点序列分型(MLST)和耐药基因分析,通过核心基因组单核苷酸多态性(SNP)比较识别推测传播事件,并结合临床元数据自动生成医院专属报告定期分发给感染控制团队。

主要发现

  • 在4年期间(2017年4月至2021年7月)共对2660株分离株进行测序,包括多药耐药革兰阴性杆菌(CPE n=293,ESBL n=1309)、MRSA(n=620)和VRE(n=433)。
  • 共发布379份临床报告。
  • 核心基因组SNP数据显示33%的分离株形成76个不同聚类。
  • 76个聚类中43个局限于3家目标医院,提示临床环境内持续传播;其余33个聚类代表可能的院际传播事件或社区流行菌株。
  • 在1家医院,非多药耐药MRSA传播可忽略的证据促使感染控制政策变更。

临床怎么用

  • 作者认为,在临床实验室对多药耐药病原体实施常规WGS是可行的,并能支持有针对性的感染预防与控制干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prospective whole-genome sequencing (WGS)-based surveillance may be the optimal approach to rapidly identify transmission of multi-drug resistant (MDR) bacteria in the healthcare setting. METHODS: We prospectively collected methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), carbapenem-resistant Acinetobacter baumannii (CRAB), extended-spectrum beta-lactamase (ESBL-E), and carbapenemase-producing Enterobacterales (CPE) isolated from blood cultures, sterile sites, or screening specimens across three large tertiary referral hospitals (2 adult, 1 paediatric) in Brisbane, Australia. WGS was used to determine in silico multi-locus sequence typing (MLST) and resistance gene profiling via a bespoke genomic analysis pipeline. Putative transmission events were identified by comparison of core genome single nucleotide polymorphisms (SNPs). Relevant clinical meta-data were combined with genomic analyses via customised automation, collated into hospital-specific reports regularly distributed to infection control teams. RESULTS: Over 4 years (April 2017 to July 2021) 2660 isolates were sequenced. This included MDR gram-negative bacilli (n = 293 CPE, n = 1309 ESBL), MRSA (n = 620), and VRE (n = 433). A total of 379 clinical reports were issued. Core genome SNP data identified that 33% of isolates formed 76 distinct clusters. Of the 76 clusters, 43 were contained to the 3 target hospitals, suggesting ongoing transmission within the clinical environment. The remaining 33 clusters represented possible inter-hospital transmission events or strains circulating in the community. In 1 hospital, proven negligible transmission of non-multi-resistant MRSA enabled changes to infection control policy. CONCLUSIONS: Implementation of routine WGS for MDR pathogens in clinical laboratories is feasible and can enable targeted infection prevention and control interventions.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Forde BM, Bergh H, Cuddihy T, et al. Clinical Implementation of Routine Whole-genome Sequencing for Hospital Infection Control of Multi-drug Resistant Pathogens. Clin Infect Dis. 2023. PMID: 36056896. doi:10.1093/cid/ciac726

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。